1.
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
by Zhang, Wendian
International Journal of Nanomedicine, 2015, pp.4825-4836

2.
Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting
by Ye, Peng
International Journal of Nanomedicine, 2014, Vol.9, pp.2167-2178
